<VariationArchive RecordType="classified" VariationID="427741" VariationName="NM_001009944.3(PKD1):c.10220+2_10220+3del" VariationType="Deletion" Accession="VCV000427741" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2017-06-10" MostRecentSubmission="2017-06-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="417443" VariationID="427741">
      <GeneList>
        <Gene Symbol="PKD1" FullName="polycystin 1, transient receptor potential channel interacting" GeneID="5310" HGNC_ID="HGNC:9008" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2088708" stop="2135898" display_start="2088708" display_stop="2135898" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NT_187607.1" start="705067" stop="760109" display_start="705067" display_stop="760109" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2138710" stop="2185898" display_start="2138710" display_stop="2185898" Strand="-" />
          </Location>
          <OMIM>601313</OMIM>
          <Haploinsufficiency last_evaluated="2020-06-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PKD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-06-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PKD1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001009944.3(PKD1):c.10220+2_10220+3del</Name>
      <CanonicalSPDI>NC_000016.10:2097724:CAC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2097725" stop="2097726" display_start="2097725" display_stop="2097726" variantLength="2" positionVCF="2097724" referenceAlleleVCF="CCA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2147726" stop="2147727" display_start="2147726" display_stop="2147727" variantLength="2" positionVCF="2147725" referenceAlleleVCF="CCA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.2097726_2097727del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.2097726_2097727del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.2147727_2147728del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.2147727_2147728del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008617.1" sequenceAccession="NG_008617" sequenceVersion="1" change="g.45495_45496del">
            <Expression>NG_008617.1:g.45495_45496del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000296.4" sequenceAccession="NM_000296" sequenceVersion="4" change="c.10217+2_10217+3del">
            <Expression>NM_000296.4:c.10217+2_10217+3del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001009944.3" sequenceAccession="NM_001009944" sequenceVersion="3" change="c.10220+2_10220+3del" MANESelect="true">
            <Expression>NM_001009944.3:c.10220+2_10220+3del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001009944.2" sequenceAccession="NM_001009944" sequenceVersion="2" change="c.10220+2_10220+3delTG">
            <Expression>NM_001009944.2:c.10220+2_10220+3delTG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645294083" DB="ClinGen" />
        <XRef Type="rs" ID="1114167366" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001009944.3(PKD1):c.10220+2_10220+3del AND Polycystic kidney disease, adult type" Accession="RCV000490641" Version="1">
        <ClassifiedConditionList TraitSetID="6385">
          <ClassifiedCondition DB="MedGen" ID="C3149841">Polycystic kidney disease, adult type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-06-10" MostRecentSubmission="2017-06-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="6385" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3359" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Polycystic kidney disease, adult type</ElementValue>
                <XRef ID="Polycystic+kidney+disease%2C+adult+type/9125" DB="Genetic Alliance" />
                <XRef ID="28728008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE I</ElementValue>
                <XRef Type="MIM" ID="173900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polycystic kidney disease 1</ElementValue>
                <XRef ID="MONDO:0008263" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polycystic kidney disease 1, severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polycystic Kidney, Autosomal Dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE</ElementValue>
                <XRef Type="MIM" ID="173900" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PKD1</ElementValue>
                <XRef Type="MIM" ID="173900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">APKD1</ElementValue>
                <XRef Type="MIM" ID="173900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Autosomal dominant polycystic kidney disease (ADPKD) is generally a late-onset multisystem disorder characterized by bilateral kidney cysts, liver cysts, and an increased risk of intracranial aneurysms. Other manifestations include: cysts in the pancreas, seminal vesicles, and arachnoid membrane; dilatation of the aortic root and dissection of the thoracic aorta; mitral valve prolapse; and abdominal wall hernias. Kidney manifestations include early-onset hypertension, kidney pain, and kidney insufficiency. Approximately 50% of individuals with ADPKD have end-stage kidney disease (ESKD) by age 60 years. The prevalence of liver cysts increases with age and occasionally results in clinically significant severe polycystic liver disease (PLD), most often in females. Overall, the prevalence of intracranial aneurysms is fivefold higher than in the general population and further increased in those with a positive family history of aneurysms or subarachnoid hemorrhage. There is substantial variability in the severity of kidney disease and other extra-kidney manifestations.</Attribute>
                <XRef ID="NBK1246" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301424</ID>
                <ID Source="BookShelf">NBK1246</ID>
              </Citation>
              <XRef ID="C3149841" DB="MedGen" />
              <XRef ID="MONDO:0008263" DB="MONDO" />
              <XRef Type="MIM" ID="173900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1127969" SubmissionDate="2017-04-06" DateLastUpdated="2017-06-10" DateCreated="2017-06-10">
        <ClinVarSubmissionID localKey="SUB2560727" submittedAssembly="hg19" title="SUB2560727" />
        <ClinVarAccession Accession="SCV000538205" DateUpdated="2017-06-10" DateCreated="2017-06-10" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, Cologne University" OrgID="243629" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PKD1">
              <Name>polycystin 1, transient receptor potential channel interacting</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001009944.2:c.10220+2_10220+3delTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="173900" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2560727</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1127969" TraitType="Disease" MappingType="XRef" MappingValue="173900" MappingRef="OMIM">
        <MedGen CUI="C3149841" Name="Polycystic kidney disease, adult type" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

